Novel In Vitro Models of Cancer

Predicting whether a potential new anticancer agent will be effective in patients remains a challenge. Murine models, the traditional preclinical hosts for cancer compound testing, have considerable limitations, and scientists are constantly searching for better technologies for in vitro tumor modeling.

In the last several years considerable progress was made in the area of 3D tissue models as well as the development of novel approaches using cancer cell lines. Cambridge Healthtech Institute’s Inaugural Novel in vitro Tumor Models conference is designed to present the latest advances in engineering and applications of novel in vitro/ex vivo tumor models.